Atezolizumab in combination with bevacizumab and chemotherapy versus bevacizumab and chemotherapy in recurrent ovarian cancer - a randomized phase III trial (AGO-OVAR 2.29/ENGOT-ov34)

Erstveröffentlichung

2020

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Harter, Philipp

Pautier, Patricia

Van Nieuwenhuysen, Els

Reuss, Alexander

Redondo, Andres

et al.

Institutions

UKU. Klinik für Frauenheilkunde und Geburtshilfe

Published in

International Journal of Gynecological Cancer ; 30 (2020), 12. - S. 1997-2001. - ISSN 1048-891X. - eISSN 1525-1438

Link to publication

https://dx.doi.org/10.1136/ijgc-2020-001572

Keywords

ovarian cancer; OPEN-LABEL; T-CELLS

Dewey Decimal Group

DDC 610 / Medicine & health

---

Metadata

Show full item record